Finland (FI)
Finland (fi)

Real-World Evidence

The FreeStyle Libre systems have been proven to improve clinical results for people living with diabetes:

  • Reduces hypoglycemia1,2
  • Lowers HbA1c3,4
  • Increases time in range for patients with T1D3
  • Improves quality of life3,5
Women with coffee smiling while the FreeStyle Libre sensor is visibile on the back of her arm.
Women with coffee smiling while the FreeStyle Libre sensor is visibile on the back of her arm.
Women with coffee smiling while the FreeStyle Libre sensor is visibile on the back of her arm.

The FreeStyle Libre systems* significantly reduces hypoglycemia in patients with both type 1 diabetes1 and type 2 diabetes2

The FreeStyle Libre-systems* significantly reduces HbA1c in patients with type 1-diabetes³

An independent study published in the New England Journal of Medicine3 shows that the FreeStyle Libre 2 system reduces HbA1c by 0.5% compared to self-measurement of blood glucose after 6 months of use.

Reduced HbA1c chart

The FreeStyle Libre-systems* increases Time in Range for patients with type 1-diabetes

FreeStyle Libre 2 users spent 2.2 hours more in Time in Range per day3

An independent study published in the New England Journal of Medicine found that FreeStyle Libre 2 users increased their time in Time in Range by over 2 hours per day:3

  • 156 patients with type 1 diabetes ≥16 years with HbA1c ≥7.5% participated in a randomized control trial

  • FreeStyle Libre 2 users spent 2.2 hours more time in Time in Range per day at 6 months of use compared to those using self-monitoring of blood glucose
Increased time chart

Makes glucose monitoring easy2 for everyone

Discover how the FreeStyle Libre range of products and apps can help manage glucose levels with ease and confidence5 for patients from age 2 years and older6,7.

FreeStyle Libre Portfolio
FreeStyle for all needs
Make glucosemonitoring easy² for everyone
Make glucosemonitoring easy² for everyone
Make glucosemonitoring easy² for everyone

References & Disclaimers

Images are for illustrative purposes only. Not real patient or data.

* FreeStyle Libre System means the FreeStyle Libre 2 System and the FreeStyle Libre 3 System. Data from these studies were collected using the FreeStyle Libre system and the FreeStyle Libre 2 system. The FreeStyle Libre 3 system has the same features as the FreeStyle Libre 2 system, therefore the study data is applicable to both products

1. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254-2263.

2. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1): 55-73.

3. Leelarathna, L. N Engl J Med. (2022): DOI: 10.1056/NEJMoa2205650.

4. Yaron, M. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166

5. Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care. 2019. https://doi:10.1136/bmjdrc-2019-000809.

6. For the FreeStyle Libre 2 and FreeStyle Libre 3,  a caregiver at least 18 years old is responsible for supervising, managing, and assisting children aged 4-12 in using the FreeStyle Libre system and interpreting its readings.

7. For FreeStyle Libre 2 Plus Sensor, a caregiver at least 18 years old is responsible for supervising, managing, and assisting children aged 2-12 in using the FreeStyle Libre system and interpreting its readings.

The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the compatibility guide for more information about device compatibility before using the app. Use of FreeStyle LibreLink may require registration with LibreView.

The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.

The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.LibreLinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. 

The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.The LibreView website is only compatible with certain operating systems and browsers. Please check www.LibreView.com for additional information

ADC-92114 v1.0 08/24

Error 500 Modal
Myfreestyle Landing Page
Myfreestyle Landing Page Secure
Login Page
Miksi FreeStyle Libre -järjestelmä?
FREESTYLE-VALIKOIMA
Tutkimus & koulutus
Uutiset & tapahtumat
TUKI
Abbott

© 2023 Abbott. All Rights Reserved. Sensorin ulkokuori, FreeStyle, Libre ja niihin liittyvät tavaramerkit ovat Abbottin tavaramerkkejä. Muut tavaramerkit ovat omistajiensa omaisuutta. Abbottin tällä sivustolla olevia tavaramerkkejä, tuotenimiä ja mallisuojia ei saa käyttää ilman Abbottin ennalta antamaa kirjallista valtuutusta muuhun kuin Abbottin tuotteiden tai palveluiden tunnistamiseen.

Tämä sivusto ja tiedot on tarkoitettu käytettäväksi Suomessa asuville henkilöille. FreeStyle Libre Flash -glukoosinseurantajärjestelmä, FreeStyle Libre 2 Flash -glukoosinseurantajärjestelmä, FreeStyle Libre 3 -jatkuva glukoosinseurantajärjestelmä, FreeStyle LibreLink -sovellus, FreeStyle Libre 3 -sovellus, FreeStyle LibreLink Special Edition -sovellus, LibreLinkUp -sovellus ja LibreView -pilvipalvelu ovat CE -merkattuja lääkinnällisiä laitteita.

FreeStyle Lite- ja FreeStyle Freedom Lite -verenglukoosin seurantajärjestelmät, FreeStyle Precision Neo -verenglukoosin ja ketoaineen seurantajärjestelmä, FreeStyle Lite-, FreeStyle Precision -verenglukoosin mittausliuskat ja FreeStyle Precision -veren β-ketoaineen mittausliuskat ovat CE -merkattuja in vitro diagnostisia lääkinnällisiä laitteita.

CE 2797. Valmistaja: Abbott Diabetes Care Ltd., Range Road, Witney, Oxon, OX29 OYL, UK. Tuotekuvia käytetään vain havainnollistamistarkoituksessa, eikä niissä ole todellisia potilaita, potilastietoja tai hoitohenkilökuntaa. Abbott Oy, Karvaamokuja 2A, 00380 Helsinki. ADC-75458 v2.0 11/23

Haluatko poistua tältä sivulta?

Alla oleva "Kyllä"-linkki vie sinut muulle kuin Abbott Laboratories -sivustolle. Linkit muille verkkosivustoille eivät ole Abbott Laboratoriesin hallinnassa, eikä Abbott Laboratories ole vastuussa tällaisten verkkosivustojen sisällöstä tai sellaisista linkeistä. Abbott Laboratories tarjoaa nämä linkit sinulle vain avuksi, eikä minkään linkin lisääminen tarkoita, että Abbott Laboratories hyväksyy sivuston.

Haluatko poistua tältä sivulta?

Sivusto on tarkoitettu Suomessa työskenteleville terveydenhuollon ammattilaisille.

Tämä on tuotekohtainen verkkosivusto, joka on tarkoitettu vain terveydenhuollon ammattilaisille Suomessa. Jos asut toisessa maassa, ota yhteyttä paikalliseen Abbott-toimistoon saadaksesi maatasi koskevat oikeat tuotetiedot.